1604 related articles for article (PubMed ID: 30585019)
1. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
2. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
Weinberg LE; Kunos CA; Zanotti KM
Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
[TBL] [Abstract][Full Text] [Related]
4. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
5. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
[TBL] [Abstract][Full Text] [Related]
7. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics and Prognostic Factors of Synchronous Endometrial and Ovarian Cancers-A Single-Institute Review of 43 Cases.
Jain V; Sekhon R; Pasricha S; Giri S; Modi KB; Shrestha E; Ram D; Rawal S
Int J Gynecol Cancer; 2017 Jun; 27(5):938-946. PubMed ID: 28498249
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
10. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531
[TBL] [Abstract][Full Text] [Related]
11. Synchronous dual primary ovarian and endometrial carcinomas.
Pearl ML; Johnston CM; Frank TS; Roberts JA
Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
[TBL] [Abstract][Full Text] [Related]
14. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
15. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.
Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438
[TBL] [Abstract][Full Text] [Related]
16. Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis.
Pecorino B; Laganà AS; Chiantera V; Ferrara M; Di Stefano AB; Di Donna MC; Sorrentino F; Nappi L; Mikuš M; Scollo P
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556908
[No Abstract] [Full Text] [Related]
17. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
[TBL] [Abstract][Full Text] [Related]
18. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
